Communicable Episode 20: Tuberculosis today
Kathryn Hostettler(European Society of Clinical Microbiology and Infectious Diseases), Angela Huttner(University Hospital of Geneva), Navaneeth Narayanan(Rutgers, The State University of New Jersey), Lorenzo Guglielmetti(Ospedale Sacro Cuore Don Calabria), Olha Konstantynovska(V. N. Karazin Kharkiv National University)
Cited by 0
Related Papers
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
|The Lancet|2018|639
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
|Intensive Care Medicine|2023|293
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
|The Lancet Infectious Diseases|2015|278
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage
|Clinical Microbiology and Infection|2019|263